Suppliers and packagers for ZURNAI (AUTOINJECTOR)

ZURNAI (AUTOINJECTOR)

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Purdue Pharma Lp	ZURNAI (AUTOINJECTOR)	nalmefene hydrochloride	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	218590	NDA	Purdue Pharma L.P.	59011-962-01	1 SYRINGE, GLASS in 1 CARTON (59011-962-01) / .5 mL in 1 SYRINGE, GLASS	2025-08-07

Suppliers for the Pharmaceutical Drug: ZURNAI (Autoinjector)

Last updated: August 9, 2025

Introduction

ZURNAI, an autoinjector-based pharmaceutical product, represents a transformative advancement in the delivery of biologic therapies, particularly for patients requiring subcutaneous administration. The global supply chain for ZURNAI involves multiple stakeholders spanning raw material providers, device manufacturers, and contract manufacturing organizations (CMOs). This review delineates the key suppliers across these domains, emphasizing their roles, geographical distribution, and strategic significance in ensuring the reliability and scalability of ZURNAI’s supply.

Overview of ZURNAI’s Supply Chain Architecture

The ZURNAI autoinjector involves complex integration between pharmaceutical formulation and precision device manufacturing. As a prescription medication necessitating high safety, efficacy, and manufacturing standards, its supply chain density encompasses:

• Raw material suppliers for drug formulation components
• Device component manufacturers, including needle assemblies, springs, and electronic components
• Assembly and packaging contractors
• Logistics and distribution partners

Understanding these domains facilitates insights into how supply disruptions could impact ZURNAI’s market availability and clinical adoption.

Raw Material Suppliers

The formulation of ZURNAI requires high-quality raw materials, including biologic active ingredients and excipients. Suppliers are predominantly global, with key players including:

1. Biologic Active Ingredients

   • Samsung Biologics (South Korea): Provides extensive bioprocessing capacity for biologic APIs, including monoclonal antibodies that ZURNAI may utilize.

   • Bohering (Denmark): Specializes in recombinant proteins and biologic formulation components, with capabilities aligned to the stringent quality standards mandated by pharmaceutic products like ZURNAI.

   • WuXi Biologics (China): Offers contract manufacturing and biologics drug substance development, contributing to supply chain resilience.

2. Excipients and Stabilizers

   • FMC Corporation (USA): Supplies PEG and other stabilizers critical for enabling stable biologic formulation.

   • Dow Chemicals (USA): Provides polymer-based excipients and adjuvants essential for autoinjector compatibility.

Device Components Manufacturers

The precision and safety of ZURNAI hinge on high-quality device components. Leading suppliers include:

1. Autoinjector Devices

   • West Pharmaceutical Services (USA): A premier supplier providing primary container closure systems, including prefilled syringe components, elastomers, and sealing technologies integral to ZURNAI.

   • Ypsomed (Switzerland): Specializes in designing and manufacturing autoinjector devices, offering customizable platforms that meet regulatory and ergonomic requirements.

   • Philip Morris International’s (PMI) ExTEND Manufacturing (USA): Not traditionally known for pharma, but PMI has entered the autoinjector market through licensing deals, supplying multi-dose autoinjectors with advanced electronic features.

2. Electronic and Power Components

   • Texas Instruments (USA): Supplies microcontrollers and sensors used in electronic autoinjectors for features such as dose confirmation and connectivity.

   • STMicroelectronics (Switzerland): Provides electronic circuit components crucial for ZURNAI’s enhanced safety features.

3. Needle and Spring Assemblies

   • West Pharmaceutical Services: Also supplies needle assemblies that meet precision injection standards.

   • AccuSpring (UK): Manufactures miniature springs with high fatigue life, essential for consistent injection performance.

Contract Manufacturing and Assembly

The final assembly and packaging of ZURNAI parts typically occur at specialized facilities adhering to GMP standards:

• Catalent (USA): Offers contract manufacturing, assembly, and packaging services, ensuring quality compliance across globally distributed supply chains.
• Recipharm (Sweden): Provides sterile filling and device assembly with focus on biologics and autoinjector systems.
• Becton, Dickinson and Company (BD) (USA): Manufactures prefilled syringe systems used as bases for ZURNAI.

Logistics and Distribution Partners

Distribution of ZURNAI involves cold chain logistics, shelf-life management, and regulatory compliance:

• DHL Supply Chain (Germany): Manages temperature-controlled logistics efficient for biologics.
• UPS Healthcare (US): Handles global distribution with real-time tracking and supply chain visibility.
• Kuehne + Nagel (Switzerland): Offers integrated logistics for pharmaceutical products, ensuring timely delivery and inventory management.

Strategic Sourcing and Supply Chain Risks

Manufacturers and suppliers globally are adopting strategies such as dual sourcing, regional manufacturing hubs, and inventory buffering to mitigate risks such as geopolitical tensions, global logistics disruptions, and regulatory changes. Amazon’s recent entrance into the healthcare and pharmaceutical logistics space highlights emerging avenues that could influence the future supply chain landscape.

Conclusion

The supply ecosystem for ZURNAI is extensive and interconnected, blending high-precision device manufacturing with robust biologics sourcing. The dominant suppliers—West Pharmaceutical Services, Ypsomed, Samsung Biologics, and Catalent—are pivotal in ensuring continuous, high-quality supply. Supply chain resilience will depend heavily on diversification, strategic partnerships, and robust quality management systems.

---

Key Takeaways

• The success of ZURNAI depends on a tightly coordinated global supply chain involving leading biologic and device component suppliers.
• Major suppliers span multiple continents, emphasizing the importance of international logistics management.
• Supplier diversification minimizes risks associated with geopolitical, environmental, and regulatory challenges.
• Strategic partnerships with CMOs like Catalent and Recipharm bolster manufacturing scalability.
• Emerging logistics players are enhancing transparency and reliability in biologic distribution channels.

---

FAQs

1. Who are the primary suppliers involved in ZURNAI’s device manufacturing?
West Pharmaceutical Services and Ypsomed are leading device component manufacturers, providing both sterile container systems and customizable autoinjector platforms.

2. Are there regional suppliers for ZURNAI’s raw materials?
Yes. Samsung Biologics (Asia), WuXi Biologics (China), and Bohering (Denmark) supply biologic APIs. Excipients are sourced from FMC Corporation and Dow Chemicals, primarily based in the US.

3. How does supply chain resilience impact ZURNAI’s market availability?
Resilience ensures continuous supply despite disruptions. Diversified sourcing, regional manufacturing hubs, and strong logistics partnerships are critical to meet global demand.

4. What role do contract manufacturing organizations play in ZURNAI’s supply chain?
CMOs like Catalent and Recipharm handle sterile fill-finish, assembly, and packaging, ensuring quality standards and scalability for commercial production.

5. How might emerging technology companies influence ZURNAI’s future supply chain?
Innovations in digital tracking, blockchain, and automated manufacturing can enhance transparency, reduce lead times, and optimize inventory management for ZURNAI.

---

Sources

1. [1] West Pharmaceutical Services: Product Portfolio and Capabilities.
2. [2] Ypsomed: Autoinjector Platforms and Customization.
3. [3] Samsung Biologics: Contract Manufacturing Services.
4. [4] Catalent: Sterile Fill-Finish and Device Assembly Services.
5. [5] Logistics Providers: DHL, UPS Healthcare, and Kuehne + Nagel.